Anestesia total intravenosa para tratamento endodôntico em Panthera leo ­ relato de caso / Total intravenous anesthesia for endodontic treatment in Panthera leo ­ case report

Animais presentes em zoológicos frequentemente necessitam de captura e anestesia para a realização de procedimentos clínicos e cirúrgicos. A anestesia total intravenosa apresenta vantagens como redução do estresse cirúrgico e menor depressão cardiovascular e respiratória. Entretanto, ainda são escassas as pesquisas dedicadas dentro deste contexto. Nesse sentido, o objetivo deste relato foi avaliar o protocolo anestésico empregado, visando um procedimento seguro e passível de reversão para a espécie silvestre selecionada. Acompanhou-se a anestesia de um leão (Panthera leo), macho, adulto, proveniente do Zoológico Municipal de Curitiba, submetido a procedimento endodôntico. A medicação pré-anestésica constituiu-se de dexmedetomidina (6 µg/kg), metadona (0,2 mg/kg), midazolam (0,1 mg/kg) e tiletamina-zolazepam (1,2 mg/kg). A indução foi realizada com propofol (1,5 mg/kg) e o animal foi intubado. Visando promover analgesia local, foi realizado bloqueio infraorbitário esquerdo com 5 mL de lidocaína a 2%. A manutenção foi realizada por meio do fornecimento de propofol (0,02-0,1 mg/kg/h), dexmedetomidina (0,5 µg/kg/h) e remifentanil (5 µg/kg/h). O paciente apresentou sedação profunda e foi mantido em plano anestésico cirúrgico; todos os parâmetros fisiológicos monitorados permaneceram estáveis durante todo o procedimento. Após 55 minutos de anestesia o paciente apresentava sustentação espontânea da cabeça, quando foi novamente transportado ao zoológico para soltura no recinto. A ambulação foi considerada normal pelos observadores no zoológico seis horas após a anestesia. Pôde-se concluir que o protocolo realizado se mostrou tanto eficaz quanto seguro para a referida espécie encaminhada ao procedimento em questão.

Zoo animals often require capture and anesthesia in order to undergo clinical and surgical procedures. Total intravenous anesthesia has advantages such as reduced surgical stress and less cardiovascular and respiratory depression. However, specific research on this matter is still scarce. Therefore, the present report aims to evaluate the anesthetic protocol employed, seeking a safe and reversible procedure for the selected wild species. A male adult lion (Panthera leo), from the Zoológico Municipal de Curitiba, was subjected to an endodontic anesthesia, under close monitoring. The pre-anesthetic medication consisted of dexmedetomidine (6 µg/kg), methadone (0.2 mg/kg), midazolam (0.1 mg/kg) and tiletamine-zolazepam (12 mg/kg). Induction was performed with propofol (1 mg/kg) and the animal was intubated. In order to promote local analgesia, a left infraorbital block was implemented with 5 mL of 2% lidocaine. Maintenance was undertaken by supplying propofol (0.02-0.1 mg/kg/min), dexmedetomidine (0.5 µg/kg/h) and remifentanil (5 µg/kg/h). The patient exhibited deep sedation and followed the surgical anesthetic plan; all the monitored physiological parameters remained stable throughout the procedure. After 55 minutes of anesthesia the patient showed spontaneous head support, when it was transported back to the zoo. The ambulation was considered normal by the zoo observers 6 hours after the anesthesia. It was concluded that the protocol was both effective and safe for the referred species undergone the procedure reported.

To Compare the Effects of Intermittent versus Continuous Administration of Epidural Ropivacaine with Fentanyl for Labour Analgesia at Govt. T.D. Medical College, Alappuzha

Labour analgesia improving the maternal and neonatal outcome is time proven. Primary objective was to compare the quality of analgesia using visual analogue scale and secondary objectives were to assess the progress of labour, incidence of instrument assisted delivery, total dose of drug used in each technique, neonatal outcome and the incidence of maternal side effects.METHODSA prospective interventional study was done in 40 willing Primigravida (20 in each group) with uncomplicated singleton term gestation admitted to labour room during the period of 1 year after obtaining ethical clearance. Sample size calculated was 25 using the formula 4pq/d2 with 80 % power. Statistical analysis was done by SPSS v16 software. Association was tested using chi square test for qualitative variables and quantitative variables was tested using independent sample t test. Statistical significance between the VAS scores was tested using Mann Whitney test.RESULTSDemographic variables, pain scores, motor block and neonatal outcome were comparable in both the groups. The total drug requirement (p-0.5) and duration of second stage (p-0.08) were less and incidence of hypotension (p - 0.29) and rescue dose requirement (p-0.6) was more in intermittent bolus group. Instrumental delivery was higher in continuous infusion group. All parturients developed urinary retention.CONCLUSIONSLow volume of 0.2% ropivacaine with 2 mcg/mL fentanyl was effective in alleviating labour pain. Both techniques were equally effective and can be recommended for labour analgesia.

Infusão de morfina e cetamina, associada ou não à lidocaína, em gatas submetidas à ovariossalpingo-histerectomia / Infusion of morphine and ketamine, with or without lidocaine, in cats undergoing ovariohysterectomy

O objetivo deste estudo foi avaliar os efeitos analgésicos transoperatórios da infusão contínua de morfina e cetamina, associada ou não à lidocaína, em gatas submetidas à OSH eletiva. Foram utilizadas 16 fêmeas adultas, hígidas, pré-medicadas com acepromazina (0,1mg/kg) e morfina (0,5mg/kg), ambas pela via intramuscular, induzidas com cetamina (1mg/kg) e propofol (4mg/kg), pela via intravenosa, e mantidas sob anestesia geral inalatória com isoflurano a 1,4 V%. Os animais foram alocados aleatoriamente em dois grupos: grupo morfina, lidocaína e cetamina (MLK, n=8), que recebeu bolus de lidocaína (1mg/kg), pela via IV, seguido de infusão de morfina, lidocaína e cetamina (0,26mg/kg/h, 3mg/kg/h e 0,6mg/kg/h, respectivamente); e grupo morfina e cetamina (MK, n=8), que recebeu bolus de solução salina, seguido de infusão de morfina e cetamina, nas mesmas doses do MLK. Os momentos avaliados foram: M0, basal, cinco minutos após a indução; M1, imediatamente após a aplicação do bolus de lidocaína ou solução salina; M2, M3, M4 e M5, a cada cinco minutos, até completar 20 minutos do início da infusão; M6, após a incisão da musculatura; M7, após pinçamento do primeiro pedículo ovariano; M8, após pinçamento do segundo pedículo ovariano; M9, após pinçamento da cérvix; M10, após sutura da musculatura; M11, ao final da cirurgia; e M12, M13 e M14, intervalos de cinco minutos, até completar uma hora de infusão. A FP no M0 foi maior no MLK quando comparado ao MK. Em ambos os grupos, a PAS foi maior no M7 e no M8 em relação ao M0, porém no MK, além da PAS, a FP foi maior do M7 ao M13, assim como a f. Os animais do MK necessitaram de um número maior de resgates transoperatorios, total de 23, do que o MLK, total de sete. Conclui-se que a adição de lidocaína incrementou a analgesia oferecida, reduzindo o número de resgates analgésicos transoperatórios, a dose total de fentanil, bem como a probabilidade de os animais necessitarem dese tipo de resgate.(AU)

The aim of this study was to evaluate the trans-operative analgesics, continuous infusion of morphine and ketamine, with or without lidocaine in cats undergoing elective OSH. Sixteen adult cats were used, otherwise healthy, pre-medicated with acepromazine (0.1mg/kg) and morphine (0.5mg/kg), both intramuscularly, induced with ketamine (1mg/kg) and propofol (4mg/kg), intravenous, maintained under general inhalation anesthesia with isoflurane 1.4 V%. The animals were randomly allocated into two groups: morphine, lidocaine and ketamine (MLK, n= 8), which received intravenous bolus of lidocaine (1mg/kg) followed by infusion of morphine, lidocaine and ketamine (0.26mg / kg/h, 3mg / kg/h and 0.6mg / kg/h, respectively); Morphine and ketamine (MK, n= 8), who received bolus of saline followed by infusion of morphine and ketamine at the same doses of MLK. The evaluated moments were: M0, basal, 5 minutes after induction; M1 immediately after the application of lidocaine bolus injection or saline; M2, M3, M4 and M5, every 5 minutes to complete 20 minutes after the start of infusion; M6, after the incision of the musculature; M7, after clamping of the first ovarian pedicle; M8, after clamping of the second ovarian pedicle; M9, after clamping of the cervix; M10, after suturing of the musculature; M11, at the end of surgery; And M12, M13 and M14, 5 minute intervals until completing one hour of infusion. The time to extubating and full recovery of animals, and the need for rescue analgesic fentanyl intraoperatively were also evaluated. HR in M0 was higher in MLK when compared to MK. In both groups the SBP was higher in M7 and M8 compared to M0, but the MK, addition of SAP, HR was greater M7 to M13, as well as f. MK animals required a greater number of trans-operative rescues than the MLK. It was concluded that the addition of lidocaine to the protocol using morphine and ketamine increased its analgesia.(AU)

Efficacy and Safety of Vancomycin Given by Continuous Infusion vs. Intermittent Infusion ：A Meta-analysis / 中国药房

OBJECTIVE：To compare the efficacy and safety of vancomycin given by continuous infusion vs. intermittent infusion，and to provide evidence-based reference for clinical drug use. METHODS ：Retrieved from PubMed ，the Cochrane Library，Embase，Wanfang database ，CNKI and VIP databases ，ranomized controlled trials （RCT）and cohort studies about vancomycin given by continuous infusion （trial group ）vs. intermittent infusion （control group ）were collected during the inception to Apr. 2020. After literature screening and data extraction ，the qualities of RCTs were evaluated by using bias risk evaluation tool recommended by Cochrane system evaluator manual 6.0. The qualities of cohort studies were evaluated by NOS ；Rev Man 5.3 software was used to perform Meta-analysis and publication bias analysis. RESULTS ：A total of 20 studies were included （3 RCTs and 17 cohort studies ），involving 2 380 patients in total. Results of Meta-analysis showed that ，target concentration attainment rate [RR ＝1.24，95％CI（1.12，1.38），P＜0.000 1] and attainment rate of target clinical efficacy [RR ＝1.20，95％CI（1.04，1.38）， P＝0.01] of trial group was significantly higher than those of control group. The incidence of nephrotoxicity [RR ＝0.56，95％CI （0.45，0.70），P＜0.000 01] was significantly lower than control group. There was no statistical significance in the therapeutic efficiency [RR ＝1.02，95％CI（0.95，1.10），P＝0.53]，drug treatment duration [MD ＝－0.50，95％CI（－1.40，0.39），P＝0.27] or mortality [RR ＝1.03，95％CI（0.78，1.35），P＝0.83] between 2 groups. The results of publication bias showed that the probability of publication bias was high when the incidence of nephrotoxicity was used as the index. CONCLUSIONS ：Vancomycin continuous infusion can improve the attainment rate of target concentration and target clinical efficacy ，reduce the incidence of nephrotoxicity ， but can not improve the treatment efficiency. Due to the inconsistent results of publication bias analysis ，the above conclusion needs to be interpreted carefully.

A Comparison of Low – Concentration Ropivacaine (0.075%) with Fentanyl Versus Bupivacaine (0.05%) with Fentanyl for Labour Epidural Analgesia

Introduction: Providing effective as well as safe analgesiato the parturients in labour is always a concerned for theanaesthesiologists. We conducted this study to compare theanalgesic efficacy and fetomaternal outcome of ropivacaineand bupivacaine at equianalgesic dose with fentanyl in lowdose infusion.Material and Methods: This prospective, single blind studywas carried on 60 nulliparous parturients of ASA grade Iand II, with uncomplicated singleton, term pregnancy. Thepatients were randomly divided into two groups, to receivebolus dose of either 20 ml of 0.075% Ropivacaine and 0.05%Bupivacaine with fentanyl 2 µg/ml in Group RF and GroupBF respectively, followed by infusion at the rate of 10ml/hr.Onset of analgesia, motor block, maternal hemodynamics,mode of delivery and foetal outcome was assessed.Results: Visual Analog Scale (VAS) score < 3 was achievedin 25 min in Group RF as compared to 30 min in Group BF. At30 min, 77% parturients achieved T10 as compared to 50% ingroup BF. Maternal haemodynamics, APGAR score, umbilicalcord blood analysis was comparable in both the groups. Noneof the patients had motor block in both groups. The percentageof instrumental delivery was more in Group RF.Conclusions: The onset of analgesia was faster in Group RFas compared to Group BF. However once the analgesia wasestablished, both the groups had effective and satisfactoryanalgesia throughout the labour with good foetal outcome.The incidence of instrumental delivery was more in Group RF.

Meta-analysis on renal toxicity of vancomycin given by continuous infusion vs in-termittent infusion / 药学实践杂志

Objective To compare the renal toxicity of vancomycin with continuous infusion vs intermittent infusion. Methods The databases of EMBASE,PUBMED,the Cochrane Register of Controlled Trials,CBM,CNKI and WanFang were searched.The Cochrane Revman5.2 software was used for Meta-analysis.Results Two RCTs and eight observational studies were included in the systematic literature search with total of 1 764 patients.1 037 patients received vancomycin with continuous infusion while 727 patients with intermittent infusion.The Meta-analysis indicated that there was no significant difference in renal toxicity between continuous infusion group and intermittent infusion group(P>0.05).Conclusion Vanco-mycin continuous infusion cannot effectively reduce the incidence of renal toxicity.

The Efficacy and Safety of Continuous Intravenous Infusion of Low-dose Epinephrine in Patients with Severe Acute Urticaria Who Do Not Achieve Sufficient Responses to Conventional Treatments: An 8-year Retrospective Study / 대한피부과학회지

BACKGROUND: Acute urticaria sometimes accompanies severe systemic reactions that can be potentially life-threatening. Some patients do not achieve sufficient responses to conventional treatments. There has been no previous study on the effect of continuous intravenous infusion of epinephrine in patients with severe acute urticaria. OBJECTIVE: This study investigated the efficacy and safety of continuous intravenous infusion of low-dose epinephrine in patients with severe acute urticaria who did not achieve a sufficient response to conventional treatments. METHODS: We retrospectively reviewed the medical records of 74 patients with severe acute urticaria who were treated with continuous intravenous infusion of low-dose epinephrine between November 2008 and December 2016. One milligram (1 mL) of 1:1000 epinephrine was diluted in 1 L of saline to yield a concentration of 1 µg/mL. The solution was infused at 0.67 µg/min (40 mL/h). Vital signs were checked at 0, 30, 60, and 90 minutes after infusion of epinephrine. Epinephrine was discontinued after one symptom-free day. RESULTS: Clinical symptoms initially resolved within 24.8 hours on average and symptoms were completely resolved within 73.4 hours on average. Twenty-four adverse events, including palpitation, chest discomfort, hand tremor, increased blood pressure, and elevated cardiac markers, were observed in 19 patients (25.7%). Most adverse events were mild and regressed spontaneously without further management. Four patients (5.4%) stopped the infusion due to adverse events, but all events regressed spontaneously after stopping epinephrine. Six weeks after completion of intravenous infusion of epinephrine, 68 patients (91.9%) were symptom-free and six patients required antihistamines. CONCLUSION: This study suggests that continuous intravenous infusion of low-dose epinephrine is a safe and effective treatment in patients with severe acute urticaria who do not achieve a sufficient response to conventional treatments.

Epidural Neuroplasty with Single Bolus Injection versus Continuous Infusion of Steroid in Patients with Spinal Stenosis

OBJECTIVE: To compare the efficacy of epidural adhesiolysis with a single bolus steroid injection (EAS) and continuous steroid infusion (EAC).METHOD: Thirty-one patients were allocated to the EAS group (10 patients) and EAC group (21 patients). EAS received single bolus of 10 mg of dexamethasone. EAC received a total of 96 mL dexamethasone solution (20.0 mg of dexamethasone) for 48 hrs. Oswestry Disability Index (ODI) was evaluated before, one month after the procedure. Three months after the procedure, the Patient’s Global Impression of Change (PGIC) was evaluated.RESULTS: Pre-treatment ODI was 38.3 ± 3.1 in EAS and 46.40 ± 4.0 in EAC. One month later, ODI was decreased to 35.60 ± 3.33, 43.08 ± 6.96 in each group (p=0.174). Three months later, 2 patients in the EAS (20.0%) and 8 patients in EAC (38.1%) showed ‘much improvement’ in PGIC, 5 patients in EAS (50.0%) and 6 patients in EAC (38.1%) showed ‘slight improvement’, 3 patients in EAS (30.0%) and 7 patients in EAC (33.3%) showed ‘no improvement’ (χ2=1.588, p=0.510).CONCLUSION: Epidural adhesiolysis with continuous infusion did not show any superiority than single bolus injection.

Administración de lidocaína en infusión continua en pacientes sometidos a procedimientos quirúrgicos abdominales oncológicos / Administration of lidocaine by continuous infusion in patients undergoing oncological adnominal surgical procedures

Introducción: La administración de lidocaína intravenosa para el control del dolor posoperatorio ha ganado interés. Su aplicación en el periodo perioperatorio a dosis baja reduce el dolor y el consumo de opioides en el posoperatorio. Objetivo: Evaluar la eficacia de la administración de lidocaína en infusión continua en el tratamiento del dolor posoperatorio en pacientes intervenidos quirúrgicamente por enfermedad abdominal oncológica. Métodos: Se realizó un estudio cuasi experimental en pacientes intervenidos por procedimiento quirúrgico abdominal oncológico a quienes se les administró infusión continua de lidocaína. Seguidamente se les evaluó la intensidad del dolor con la escala visual análoga. Esta se aplicó a los 30 min, 2, 6, 12 y 24 h después de la operación. Se determinó la presencia o no de complicaciones intra- y posoperatorias. Resultados: Los pacientes entre 31 y 50 años de edad prevalecieron en ambos grupos. El sexo masculino predominó en el grupo estudio y el femenino en el control. En el grupo estudio la respuesta no fue satisfactoria solo en dos pacientes, en 11 pacientes fue satisfactoria, en el testigo en cinco pacientes fue no satisfactoria. En el grupo estudio tres pacientes tuvieron dolor por menos de 2 h y fue catalogado entre ligero y moderado. En el control 12 presentaron dolor por más de 4 h catalogado entre moderado y grave. En dos pacientes aparecieron efectos adversos. Conclusiones: Con la administración de lidocaína se logra una disminución del dolor y del consumo de opioides(AU)

Introduction: The intravenous administration of lidocaine for postoperative pain control has gained interest. Its administration in the perioperative period and at a low dose reduces postoperative pain and opioid use. Objective: To evaluate the effectiveness of continuous infusion of lidocaine in the treatment of postoperative pain in surgically intervened patients with oncologic abdominal disease. Methods: A quasiexperimental study was performed in patients undergoing oncologic abdominal surgical procedures and who were given continuous infusion of lidocaine. The pain intensity was then evaluated with the analogue visual scale. This was applied after 30 minutes, two, six, twelve and twenty-four hours after the operation. The presence or absence of intraoperative and postoperative complications was determined. Results: Patients aged 31-50 prevailed in both groups. The male gender predominated in the study group and the female gender, in the control group. In the study group, the response was not satisfactory only in two patients, while it was satisfactory in 11 patients; in the control group, it was not satisfactory in 5 patients. In the study group, three patients had pain for less than 2 hours and this was classified as mild to moderate. In the control group 12 of them presented pain for more than 4 hours, which was classified as moderate and severe. Adverse effects appeared in two patients. Conclusions: The administration of lidocaine leads to a decrease in pain and opioid consumption(AU)

Comparison of programmed intermittent epidural bolus with continuous epidural infusion at different time intervals for epidural labor analgesia / 临床麻醉学杂志

Objective To investigate the effects of programmed intermittent epidural bolus (PIEB) with continuous epidural infusion (CEI) at different time intervals for epidural labor analgesia.Methods One hundred and eighty-six nulliparous parturients were randomized to the groups P1, P2 and C.Epidural infusion was given initial loading dose: 10 ml (0.125% ropivacaine with 0.4 μg/ml sufentanil), followed by maintaining dose: 0.08% ropivacaine with 0.4 μg/ml sufentanil.Group P1 was given basal infusion 5 ml per 30 min, 30 min after the initial dose;group P2 was given basal infusion of 10 ml per 60 min, 60 min after the initial dose;CEI basal infusion of 10 ml/h immediately after the initial dose;PCEA (patient-controlled epidural analgesia dose) 5 ml (lockout interval: 30 min).The baseline maternal heart rate, noninvasive arterial blood pressure, SpO2, respiratory rate, and fetal heart rate tracing were recorded.The visual analog scale (VAS) was recorded during the first stage of labor and at full cervical dilation.The degree of motor block was assessed in both lower extremities using the modified Bromage score (MBS).The maximum blocked segment, the consumption of anesthetic, delivery mode, amount of oxytocin, The number of cases of motor block and intrapartum fever, the fetal Apgar scores,adverse reactions,maternal satisfaction score were recorded.Results The VAS obviously decreased in the three groups since receiving labor analgesia (P<0.05).The ratio of VAS score more than 3 scales in group PIEBⅡ was significantly lower than that in groups P1 and C (P<0.05).The maximum blocked segment increased in group P1, while The incidence of unilateral block was significantly decreased in group P2 (P<0.05).The total drug consumption.And the toatal number of PCA were decreased obviously in group PIEB (P<0.05).The initial PCA time was significantly prolonged in group P2 (P<0.05).The number of instrumental midwifery and intrapartum fever in group P2 were significantly lower than that in group C (P<0.05).Conclusion Programmed intermittent epidural bolus at the beginning 60 min intervals after the initial dose for epidural labor analgesia is scientific and effective.

Outcomes and rational clinical use of extended or continuous versus intermittent infusion of piperacil-lin/tazobactam / 中国药学杂志

OBJECTIVE: To introduce the research progress of dosage regimen of piperacillin/tazobactam and its rational offer reference for clinical use. METHODS: The domestic and oversea pertinent articles were searched, analyzed and summarized, and the difference between prolonged infusion or continuous infusion and traditional infusionin pharmacodynamics and clinical trials were compared. RESULTS: The optimized dosage regimen could achieve higher pharmacodynamics goals, with clinical efficacy and bacterial clearance not inferior to the traditional dosage regimen. CONCLUSION: The prolonged or continuous infusion strategy should be recommended for piperacillin/tazobactam in the clinic.

Teicoplanin concentration in cerebrospinal fluid during intravenous infu-sion in patients following neurosurgery operation / 中国感染控制杂志

Objective To understand teicoplanin concentration in cerebrospinal fluid (CSF)during intravenous in-fusion in patients following neurosurgery operation,and evaluate whether drug concentration can be increased if blood-brain barrier was damaged, and effect of continuous pump of drug on drug concentration in CSF. Methods The post-neurosurgical surgery patients with surgical site/ventricular drainage were enrolled in the study, patients were divided into routine administration group(a dose of teicoplanin of 400 mg/12 h was administered for 30 min)and continuous administration group (a dose of 400 mg teicoplanin was administered for 30 min followed by a continuous infusion of 200 mg/6 h).CSF specimens were collected at respective time points of administration, teicoplanin concentration in specimens was measured.Results For routine administration group,drug concentration in CSF was (0.004 ± 0.0123 )mg/L immediately after teicoplanin was bumped,the peak concentration was (0.712 ± 1.028)mg/L after 1-hour bumping,then concentration decreased gradually,which were (0.254 ±0.222),(0.173 ± 0.152),and (0.355±0.207)mg/L at 12,18,and 24 hours of bumping respectively.For continuous administration group, drug concentration in CSF was(0.017±0.020))mg/L immediately after teicoplanin was bumped,the peak concentration reached (0.587±0.255)mg/L after 4-hour bumping,then concentration were (0.429±0.416),(0.325±0.254),(0.476 ±0.686),and (0.318 ±0.464)mg/L at 6,12,18,and 24 hours of bumping respectively,teicoplanin concentration was relatively stable 6 hours later,which were (0.318±0.464)mg/L-(0.476±0.686)mg/L.The area under the curve during 24 hours (AUC0-24 )in routine administration group and continuous administration group were 5.590 mg/L·h and 9.082 mg/L·h respectively.For two groups of patients,teicoplanin concentration only at the area near peak value a-chieved 50% minimum inhibitory concentration(MIC50 )for coagulase negative staphylococcus (CNS),but the time for a-chieving concentration higher than CNS MIC50 was far less than 50% of total administration time;teicoplanin concentration in CSF of both groups of patients didn’t achieve MIC50 for Staphylococcus aureus .Conclusion After continuous infusion of teicoplanin,drug concentration in CSF can be increased compared with routine administration group,but still can’t achieve the effective MIC;the increase of blood drug concentration is benefit to drug concentration in CSF,it is necessary to in-crease the dose appropriately to achieve clinical effectiveness.

Current situation of evaluation and application with alternative dosing regimens for piperacillin sodium-tazobactam sodium / 药学实践杂志

Objective To offer reference to reasonable clinical use of piperacillin sodium sodium-tazobactam sodium .Methods We reviewed pharmacokinetic/pharmacodynamic studies , clinical trails and implementation of piperacillin sodium-tazobactam sodi-um alternative dosing regimen in recent .Results The alternative dosing regimens , prolonged and continuous infusion , could maximise the likelihood of achieving desirable pharmacodynamic targets and improve clinical effectiveness .Conclusion It’ s needed to improve the strategies of alternative dosing regimens for clinical practice .

Progress of in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitution

BACKGROUND: Continuous infusion of factor VIII (FVIII) is a more cost-effective method for treating hemophilia A than intermittent bolus injection. However, there is currently no specific data in Korea about the progress of in vitro FVIII coagulant activity (FVIII:C) after reconstitution from its lyophilized form. METHODS: Three commercial FVIII concentrate products (two recombinant FVIII and one plasma-derived) were used. In vitro FVIII:C was measured at 0, 2, 4, 6, and 8 hours following reconstitution in both the indoor light-exposed and light-shielded groups. RESULTS: For the three drugs, in vitro FVIII:C decreased over the 8 hours following reconstitution (P<0.001). The decline of FVIII:C was linear (P<0.001). In vitro FVIII:C for the indoor light-exposed groups was 95.3+/-1.9% and 90.6+/-2.5% after 4 and 8 hours following reconstitution, respectively, compared to baseline activity. In the light-shielded group, FVIII:C was 95.4+/-1.1% and 90.9+/-1.7% of the baseline activity after 4 and 8 hours, respectively. There was no statistical difference between FVIII:C in the indoor light-exposed and light-shielded groups (P=0.849). CONCLUSION: In vitro FVIII:C decreased after reconstitution, but activity was maintained at over 90% of the baseline value during 8 hours. Exposure to indoor light did not accelerate the loss of FVIII:C over the experimental time. This result indicates that CI with FVIII is available in 8-hour intervals, with no indoor light-exposure precautions needed.

Farmacocinética do propofol em nanoemulsão em gatos / Pharmacokinetic of propofol in nanoemulsion in cats

Os felinos são deficientes na biotransformação do propofol e os dados em relação à farmacocinética nessa espécie são escassos. O objetivo deste estudo foi determinar o perfil farmacocinético da infusão contínua de propofol em nanoemulsão juntamente com a emulsão lipídica em felinos. Utilizaram-se seis gatos sem raça definida (SRD), adultos, machos, castrados, com peso médio de 4,2±0,8kg, em estudo aleatório e de autocontrole. Os animais receberam 10mg kg-1 min-1 de propofol a 1% em emulsão lipídica (EMU) ou em nanoemulsão (NANO) durante 30 segundos e, imediatamente após, iniciou-se a infusão de 0,3 mg kg-1 min-1 da mesma formulação durante 60 minutos. Após 15 dias, receberam o mesmo tratamento com a formulação oposta. Amostras de 3mL de sangue venoso foram coletadas nos tempos 0 (basal), 2, 5, 10, 15, 30 e 60 minutos de infusão e aos 5, 10, 15, 30, 60, 90, 120, 180, 240, 360, 600 e 1440 minutos após o final da infusão. Os parâmetros farmacocinéticos foram determinados a partir da curva de decaimento da concentração plasmática versus tempo ao final da infusão. A análise estatística foi realizada através de ANOVA-RM com posterior teste t pareado entre os grupos. Não houve diferença entre as formulações em relação a todos os parâmetros. Os volumes de distribuição foram altos com Vdss de 23,23±12,30 litros kg-1 para a nanoemulsão e de 18,12±8,54 litros kg-1 para a emulsão lipídica. Os Cls foram baixos com um Cl central de 22,20±10,83mL kg-1 min-1 para a nanoemulsão e de 23,42±13,50mL kg-1 min-1 para emulsão lipídica. Conclui-se que a farmacocinética do propofol em gatos após infusão contínua caracteriza-se por uma ampla distribuição tecidual e uma lenta eliminação, com possível efeito cumulativo. A formulação em nanoemulsão apresenta características farmacocinéticas semelhantes às da emulsão lipídica.

Cats are deficient in the metabolism of propofol and the data on the pharmacokinetics in this species are scarce. The aim of this study was to determine the pharmacokinetic profile of continuous infusion of propofol in lipid emulsion and compare with the nanoemulsion formulation, in cats. Domestic cats, short hair, adults, male, castrated, weighting 4.2±0.8kg in a randomized and self control trial were used. The animals received 10mg kg-1 of 1% propofol in lipid emulsion or nanoemulsion for 30 seconds and immediately after that, a continuous rate infusion of 0.3mg kg-1 min-1 of the same formulation was administered for 60 minutes. After 15 days the cats received the same treatment with the opposite formulation. Samples of 3mL of venous blood were collected by a central venous catheter inserted in the jugular vein at 0 (baseline), 2, 5, 10, 15, 30, and 60 minutes of infusion and at 5, 10, 15, 30, 60, 90, 120, 180, 240, 360, 600 and 1440 minutes after the end of the infusion. The pharmacokinetic parameters were determined from the decay curve of plasma concentration versus time at the end of the infusion. Statistical analysis was performed using RM-ANOVA with subsequent paired t-test between groups. There was no difference between the formulations with respect to all parameters. The volumes of distribution were high with Vdss of 23.23±12.30 liters kg-1 for the nanoemulsion and 18.12±8.54 liters kg-1 for lipid emulsion. The Cls were low with a Cl central to 22.20±10.83mL kg-1 min-1 for the nanoemulsion and 23.42±13.50mL kg-1 min-1 for lipid emulsion. The conclusion is that the pharmacokinetics of propofol in cats after infusion is characterized by a broad tissue distribution and a slow elimination, with possible cumulative effect. The formulation nanoemulsion has pharmacokinetic properties similar to the lipid emulsion.

Vancomicina en infusión continua en pacientes pediátricos críticos / Continuous infusion of vancomycin in pediatric critical care

La administración de vancomicina en infusión continua es una estrategia de tratamiento posible en pacientes críticos que no alcancen niveles plasmáticos adecuados. Existe escasa bibliografía acerca de este tipo de administración. Se presentan 6 niños (2 meses a 7 años; 4 varones y 2 mujeres) que ingresaron en la unidad de cuidados intensivos del Hospital de Pediatría Garrahan con un cuadro clínico de sepsis por Staphylococcus aureus resistente a la meticilina, tratados con vancomicina, en dosis de entre 40 y 60 mg/kg/día cada 8-6 horas. Debido a la evolución clínica no favorable, la persistencia de la fiebre, los cultivos positivos y los niveles plasmáticos del antibiótico insuficientes, se implementó la infusión continua a 50 mg/kg/día. Todos los pacientes alcanzaron niveles entre 10 y 25 µg/ml, evolucionaron favorablemente y negativizaron los cultivos, sin signos de nefrotoxicidad. El tiempo de tratamiento en infusión continua fue entre 9 y 18 días. La infusión continua de vancomicina fue eficaz en estos pacientes, sin evidencias de nefrotoxicidad asociada.

Continuous infusion of vancomycin may be a strategy for critically ill patients who do not achieve adequate plasma levels. There is few literature on this dosage regimen. We present six children (2 months to 7 years, 4 male and 2 female), admitted to the Intensive Care Unit of the "Prof. Dr. Garrahan Children Hospital", with methicillin-resistant Staphylococcus aureus sepsis, treated with vancomycin 40 and 60 mg/kg/day every 8-6 hrs. Continuous infusion at 50 mg/kg/day was implemented due to poor outcome, persistent fever, positive cultures and inadequate vancomycin plasma levels. All patients achieved levels between 10 and 25 ug/ml, their outcome was favorable and cultures became negative, with no signs of nephrotoxicity. Treatment duration of the continuous infusion was 9 to 18 days. Continuous infusion of vancomycin was effective in these patients without evidence of associated nephrotoxicity.

Epidural catheter elongated through subcutaneous tunnel from the puncture site to the frontal abdominal wall in terminally ill cancer patients: a report of 3 cases

Continuous epidural injection of opioid/local anesthetic drugs can be a useful tool to alleviate intractable pain in cancer patients. The use of an epidural catheter, however, always faces with contamination and infection. In order to avoid contamination, an injection port is often implanted in the subcutaneous space and intermittent or continuous injection is employed. The injection port requires an additional cost and a little more time for implantation. Both the cost and the time-requiring procedure may be of problem in the terminally ill cancer patients. We present 3 cases of cancer patients with high risk of catheter contamination treated with continuous epidural injection using catheters elongated through subcutaneous tunnel from the epidural puncture site to the front side of abdominal wall. The risk factors of the patients were; subcutaneous emphysema due to intestinal perforation in a 81 yr male with bladder cancer, local abscess and MRSA infection in a 45 yr female with uterine cancer, and cutaneous tissue disruption in a 51 yr female with lung cancer and multiple metastasis. The duration of epidural analgesia were 22, 26, and 21 days until the patient's death, respectively. Although the risk of epidural catheter contamination and infection was extremely high in all three patients, continuous epidural injection for more than 3 weeks was possible with favorable analgesic effects. Use of an epidural catheter elongated through subcutaneous route from the puncture site to the frontal abdominal wall offers a practical and inexpensive way in patients with intractable pain at least for a few weeks. Palliat Care Res 2011; 6(2): 350-357

Avaliação do conhecimento de enfermeiros sobre a importância da infusão contínua de catecolaminas em unidade de terapia intensiva / Evaluacion del conocimiento de los enfermeros sobre la importancia de la infusion continua de catecolaminas en la unidad de cuidados intensivos / Assessment of nurses’ knowledge about the importance of continuous infusion of catecholamines in intensive care unit

O objetivo com este estudo foi avaliar o conhecimento de enfermeiros intensivistas sobre a importância da infusão contínua de catecolaminas. Trata-se de estudo descritivo, exploratório com delineamento transversal, desenvolvido em Unidades de Terapia Intensiva de um Hospital Escola no município de Fortaleza-CE. Foram entrevistados 49enfermeiros. A maioria, 80,4% (40), declarou, ainda, que não tinha o título de especialista em terapia intensiva. Os dispositivos mais utilizados para a infusão contínua de catecolaminas foram bombas infusoras e equipos com injetores laterais (93, 88%). Dado preocupante foi encontrado quando 54,34% dos entrevistados relataram que não obedeciam rigorosamente à infusão contínua. Em relação à investigação do conhecimento dos enfermeiros sobre a importância do conceito farmacológico desse tipo de infusão, 57,14% da amostra demonstrou dominar de forma parcial a importância farmacológica do conceito de infusão contínua. Conclui-se que a elaboração de protocolos especificando a necessidade de troca continuada das soluções possa auxiliar significativamente a assistência de enfermagem.

The aim of this study was to evaluate the nurses’ knowledge about the importance of continuous infusion of catecholamine. This is a descriptive exploratory cross-sectional study conducted in the Intensive Care Unit of a teaching hospital in Fortaleza-Ceará. We interviewed 49 nurses. The majority 80.4% (40) were not specialists in intensive care.The most used device for the continuous infusion of catecholamines were infusion pumps and jet-directed catheter(93. 88%). Worryingly 54.34% of the nurses interviewed stated they do not strictly comply with the continuous infusion.Regarding the investigation of nurses’ knowledge about the importance of the pharmacological concept of that drug infusion 57.14% partially dominate the pharmacological importance of the concept of continuous infusion. In conclusion the development of protocols that specify the need for continuous solutions exchange can help significantly the nursing care assistance.

El objeto de este estudio fue evaluar el conocimiento de los enfermeros sobre la importancia de la infusión continua decatecolaminas. Se trata de un estudio exploratorio descriptivo llevado a cabo en la Unidad de Cuidados Intensivos de un hospital universitario de Fortaleza-Ceará. Se realizaron entrevistas con 49 enfermeras. La mayoría, el 80,4% (40), no era especialista en terapia intensiva. Los dispositivos más utilizados para la infusión de catecolaminas eran la bomba de infusión y el catéter (93, 88%). 54,34% de los entrevistados informó que no seguía estrictamente la infusión continua.En cuanto a la investigación del conocimiento de los enfermeros sobre la importancia del concepto de infusión de medicamentos el 57,14% de la muestra indicó dominar parcialmente la importancia farmacológica del concepto de infusión continua. Se concluye que la elaboración de protocolos especificando la necesidad de cambiar las soluciones podría ayudar significativamente a la atención de enfermería.

Research in effect of hirudoid on phlebitis prevention initiated by continuous infusion of 5-Fu with Baxter infusor / 中国实用护理杂志

Objective We observed the effect of topical application of mucopolyccharide polysulfate cream (hirudoid) on phlebitis prevention initiated by continuous infusion of 5-Fu with Baxter infusor. Methods 60 untreated patients with nasopharyngeal carcinoma were selected and randomly divided into the control group (28 patients) and the experimental group (32 patients). The patients of the experimental group were gently massaged with hirudoid along the infusion vein since the beginning of 5-Fu infusion, while the control group received no intervention. The incidence of phlebitis was observed in the two groups. Results The incidence of phlebitis in the experimental group was lower and the degree was lighter compared with the control group. Conclusions Hirudoid can decrease the incidence and released the symptoms of phlebitis initiated by continuous infusion of 5-Fu with Baxter infusor, and is effective to prevent and treat phlebitis.

Long-term Outcomes of Patients with Newly Diagnosed NK/T-cell Lymphoma Treated by EPOCH Regimen / 中山大学学报(医学科学版)

[Objective]This study was aimed to evaluate treatment outcomes and toxicity of continuous-infusion EPOCH regimen for NK/T-cell lymphoma(NK/TCL).[Methods]From June 2003 to June 2008,34 patients including 30 nasal NK/TCL (88.2%)and 4 nasal type NK/TCL(11.8%)received doxorubicin,vincfistine,etoposide over 96 hours infusion with bolus eyelophosphamide and oral predinisone(EPOCH)chemotherapy as first-line treatment.Median cycles of EPOCH administered were 2.5(1-6 cycles).Additional involved field radiation therapy(IFRT)was administered to patients with localized nasal focus after chemotherapy.[Results]Among 34 patients,33 were eligible for response evaluation.The response rate(RR)was 60.6% (20/33)with complete remission(CR)rate of 45.5%(15/33).The RR of patients with nasal NK/TCL was 66.7%(20/30)with CR rate of 50%(15/30).Only one of the 3 nasal type NK/TCL patients achieved stable disease(SD),the other 2 had progressive disease(PD)during chemotherapy.After a median follow-up of 22(2-68)months,the estimated 3-year overall survival rate(OS)was 52.2%.For patients with nasal NK/TCL,the estimated median survival time was not reached,the 3-year OS was 59.4%.For patients with nasal type NK/TCL,the estimated median survival time was only 7 months.The CR rate was 75.0% for localized nasal NK/TCL who received initial EPOCH chemotherapy followed IFRT with the 3-year OS of 75.0%.Major adverse effect was myelosuppression.The incidence of grade Ⅲ～Ⅳ neutropenia was 30.9%.No treatment-related mortality occurred.[Conclusions]EPOCH regiment was effective and well tolerant for nasal NK/TCL.Combined EPOCH chemotherapy followed by IFRT produced promising outcome for patients with localized disease.However,patients with nasal type NK/TCL responded poorly and more efficacious treatment strategies are urgently needed.